Squamous cell carcinoma of skin of left upper limb, including shoulder
ICD-10 C44.629 is a billable code used to indicate a diagnosis of squamous cell carcinoma of skin of left upper limb, including shoulder.
Squamous cell carcinoma (SCC) is a common form of skin cancer that arises from the squamous cells in the epidermis. This malignancy is often associated with prolonged sun exposure, which can lead to DNA damage in skin cells. The left upper limb, including the shoulder, is a common site for SCC due to its exposure to ultraviolet (UV) radiation. Clinically, SCC may present as a persistent, non-healing sore, a scaly patch, or a wart-like growth. Diagnosis is typically confirmed through a biopsy, which reveals atypical squamous cells. Treatment options include surgical excision, Mohs micrographic surgery, and in some cases, radiation therapy or topical chemotherapy. Surgical margins are critical in SCC management; clear margins are essential to reduce the risk of recurrence. Reconstruction may be necessary depending on the size and location of the excised lesion, with options ranging from simple closure to more complex flap or graft procedures. Regular follow-up is important to monitor for recurrence or new skin cancers, especially in patients with a history of sun exposure or previous skin malignancies.
Detailed descriptions of the lesion, biopsy results, and treatment plans.
Diagnosis and treatment of SCC, follow-up for skin cancer surveillance.
Ensure clear documentation of margins and any reconstructive procedures performed.
Comprehensive treatment plans, including chemotherapy or radiation therapy details if applicable.
Management of advanced SCC, coordination of care with surgical teams.
Document any systemic therapies and their effects on the patient's overall health.
Used when excising a large SCC on the left upper limb.
Document the size of the lesion and margins.
Dermatology and surgical oncology should ensure clear communication on margins.
Documenting surgical margins is crucial as it indicates whether the cancer has been completely excised. Clear margins reduce the risk of recurrence and are essential for accurate coding and billing.
